Literature DB >> 19338663

Antiviral therapy in acute viral hepatitis B: why and when.

Giuseppe Morelli1, Alessandro Perrella, Costanza Sbreglia, Pasquale Bellopede, Vincenzo Riccio, Antonio Monaco, Oreste Perrella.   

Abstract

Correction to Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O: Antiviral therapy in acute viral hepatitis B: why and when. Infectious Agents and Cancer 2009, 4:2.

Entities:  

Year:  2009        PMID: 19338663      PMCID: PMC2672065          DOI: 10.1186/1750-9378-4-5

Source DB:  PubMed          Journal:  Infect Agent Cancer        ISSN: 1750-9378            Impact factor:   2.965


Correction

After publication of this work [1], we noted that we inadvertently failed to include the complete list of all coauthors. The full list of authors has now been corrected here and the Authors' contributions and Competing interests section modified accordingly (see below).

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

GM, AP were involved in preparation of data analysis, preparation of the manuscript and study coordination; CS, PB, VR, AM were involved in clinical investigation; OP was involved in idea writing of the manuscript, principal investigator and responsible for the study.
  1 in total

1.  Antiviral therapy in acute viral hepatitis B: why and when.

Authors:  Giuseppe Morelli; Alessandro Perrella; Costanza Sbreglia; Pasquale Bellopede; Vincenzo Riccio; Oreste Perrella
Journal:  Infect Agent Cancer       Date:  2009-01-16       Impact factor: 2.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.